Societal CDMO is a contract development and manufacturing organization, solving formulation and manufacturing challenges primarily in small molecule therapeutic development. Co. utilizes its formulation and development knowledge to develop and manufacture pharmaceutical products using proprietary delivery technologies and know-how for partners who develop and commercialize or plan to commercialize these products. Co. has launched its clinical trials support services capabilities, which includes preparation of clinical trial supplies, as well as services dedicated to the development and Good Manufacturing Practices, of high-potency products. We show 5 historical shares outstanding datapoints in our coverage of SCTL's shares outstanding history.
Understanding the changing numbers of SCTL shares outstanding — and
comprehending the concept of differing number of shares outstanding in general comparing companies like SCTL versus peers —
is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies.
Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history.
With this page we aim to empower investors researching SCTL by allowing them to research SCTL shares outstanding history
as well as any other stock in our coverage universe. |
Free SCTL Email Alerts:
Video: Shares Outstanding Importance
